Lucien Blondel on Resolve Stroke: To Be Used In the SCULPT Trial
Lucien Blondel, Co-Founder of Quantum Surgical, shared on LinkedIn:
”Resolve Stroke, a French startup developing an ultrasound-based solution to accelerate time to treatment, announced enrollment of first patient in the SCULPT trial.
Over a 6 month period, data will be collected for up to 50 patients of the neuro-intensive care unit at Montpellier University Hospital.
In ICU, patients admitted after brain injuries require daily monitoring.
Traditional X-ray based imaging is the gold standard but has limitations: transporting vulnerable patients, radiation exposure, logistics, etc.
The company led by Aritz Zamacola is betting on advanced software that would transform raw acoustic data into biomarkers.
The SYLVER system enables live imaging of cerebral vasculature and perfusion directly at patient’s bedside.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 10:23Danny Hsu: Honouring Rob Bird’s Career and Impact in Haematology
-
Sep 5, 2026, 10:12Wolfgang Miesbach: Can Emicizumab Be Used During Breastfeeding?
-
Sep 5, 2026, 09:52Lorena Arranz: Shaping the Future of Hematology with EHA 2027
-
Sep 5, 2026, 07:35Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
-
Sep 5, 2026, 05:48Punit Mathur: From Leg Pain to Life-Threatening Pulmonary Embolism
-
Sep 5, 2026, 05:44Patrick Stonich: Identifying Missed Signs of Postoperative Pulmonary Embolism in Medical Record Reviews
-
Sep 5, 2026, 05:38Tom Van den Hoek: Warburg Effect Mimicking Refractory Shock in Cancer-Associated PE
-
Sep 5, 2026, 05:11Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
-
Sep 5, 2026, 04:56Opportunities for the Next Generation of Hematologists – American Society of Hematology